about
Peroxisome proliferator activated receptor gammaAGTCD36 moleculeFas ligand (TNF superfamily, member 6)Leukemia inhibitory factorCatenin (cadherin associated protein), beta 1Platelet factor 4Secreted acidic cysteine rich glycoproteinChemokine (C-X-C motif) ligand 10Transforming growth factor, beta 2APOHApolipoprotein HChemokine (C-X3-C motif) receptor 1Chemokine (C-X-C motif) receptor 3Transcription factor 4PleiotrophinPleiotrophinCatenin beta 1ProlactinHeparan sulfate proteoglycan 2TEK receptor tyrosine kinaseAngiopoietin 4Rho associated coiled-coil containing protein kinase 1Natriuretic peptide receptor 1Thrombospondin 2DAB2 interacting proteinPML nuclear body scaffoldProtein tyrosine phosphatase receptor type MHomeobox A5Forkhead box O4Forkhead box J2Serpin family F member 1Sprouty RTK signaling antagonist 2Argonaute RISC component 1Hematopoietically expressed homeoboxMethyl-CpG binding protein 2ATP binding cassette subfamily C member 8Kruppel like factor 4EPH receptor A2Isthmin 1
P682
Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growthThe new human kallikrein gene family: implications in carcinogenesisCrystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factorPlasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesisCD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivoRegulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptidesHuman tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrinsPML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTORThe forkhead transcription factor FOXO4 induces the down-regulation of hypoxia-inducible factor 1 alpha by a von Hippel-Lindau protein-independent mechanismChondromodulin-I maintains cardiac valvular function by preventing angiogenesisCleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesisFlexible heteroarotinoid (Flex-Het) SHetA2 inhibits angiogenesis in vitro and in vivoA mechanosensitive transcriptional mechanism that controls angiogenesisNovel antiangiogenic pathway of thrombospondin-1 mediated by suppression of the cell cycleGhrelin inhibits FGF-2-mediated angiogenesis in vitro and in vivoInhibition of Rho-dependent kinases ROCK I/II activates VEGF-driven retinal neovascularization and sprouting angiogenesisMicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivoThe paradox of paclitaxel neurotoxicity: Mechanisms and unanswered questionsVasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor.Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1.Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesisWISP3 is a novel tumor suppressor gene of inflammatory breast cancer.MicroRNA-30b controls endothelial cell capillary morphogenesis through regulation of transforming growth factor beta 2.Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity.MINAR1 is a Notch2-binding protein that inhibits angiogenesis and breast cancer growth.
P921
Q1084878-F7EFA61A-656D-412F-944D-4F45CBF33265Q14859647-23A4322B-24EA-4F2C-BF3D-DC3EC72B4CB4Q14864583-01DD9E77-6D6C-480B-8C86-C80186D02BEFQ14866122-4C9C34D0-2ADD-4256-8071-815ADFC1CFDCQ14878799-A5B1C263-8341-4F1F-A37D-272804E7BD51Q14902827-9FBAB666-40E5-457C-9BB4-F98F4C847CEDQ14905361-AB5C2606-C52B-49BA-8EA5-DD3D3CA82783Q14906164-4C95730D-2298-43EF-BFA0-91E06F5DDD91Q14907806-7A1BA8BC-0648-49CA-808C-F211C57DEEC6Q14907806-A3EFC476-6676-4074-9644-B087F39EE4CAQ14908058-103B6742-8801-46DE-B12C-40035FE23608Q14911006-3A07FD47-A6D2-44FA-A547-31CBB0AC07EAQ14911041-607F6C23-FB79-49CF-8322-E5CB10374A85Q14911551-2B638D78-0533-4257-81BC-1681465DDC70Q14911981-ABFB9636-6EFB-4FE4-9347-4B4F1AC7AF4FQ14913984-08C753B9-4FE9-42CC-A225-6157BC14E8A2Q14916157-F5BBB2A6-BAB0-4FBC-8647-CB83FAB5AFC0Q14916162-369125B8-7587-49EC-8E6E-77C6808687DFQ1634046-511B50B5-6014-47A3-8405-C3584F380528Q192191-5F9A5460-BEDB-455B-B2C3-742E1D9B48D0Q2071346-B4C8231C-7032-42B3-A9CD-31BFF3A53954Q21097266-25453780-E274-4D79-9E5D-3CE880E3D056Q21097371-CDC76F69-C35B-425F-BF02-DF9BEC8C0BA0Q21100658-2C4223E6-B1F3-4CB5-83AE-53FE8112C5C6Q21105144-B832D97A-E2FD-4A35-AC40-E15B95E49644Q21105497-5463C883-84CA-4016-BF24-A978B3119FEFQ21105497-82DB70C4-9620-4F2E-8F80-85F1A16096A6Q21105736-C97EC034-5B66-47CA-BA5A-141E55374BF1Q21106974-D3241C33-7D52-4634-8895-E0CEF78B4320Q21108320-C703038C-B728-4D1F-A1B9-572FDC51C530Q21108736-946FBA4A-C794-4E82-A362-A44F6A596975Q21109294-DEDF0647-4E4D-4B45-AA66-C366A8FB9EDEQ21110144-9EF5DC7D-BEF0-4A0A-81CB-A02F91A2AD2EQ21110882-08C37DBD-0083-4CCA-AAFD-C3703547EDCDQ21111117-0B46C647-5FED-4608-BA10-3A22E0E5A37CQ21111286-5BC81367-AA13-4730-896C-C18982195CFAQ21113391-6EB67C67-60B5-4E6D-9E4F-53806499E189Q21113391-CBAB2616-B8E5-4A2F-B7A1-956A5411EDDBQ21113404-95FB4661-6CA2-4ED5-936D-E2D9C03DBDDDQ21113671-1B0B6590-2AF6-42DD-A134-F6C82E540839
P682
Q22011031-48136692-D891-431A-B566-5580A4C180A0Q22253190-212A4664-D2EC-4EAF-8AA1-A979B283DB30Q24291702-0C13540A-3E33-47F8-9D20-EADA5ECF82A1Q24293734-B9B144C9-6A86-4D7F-A0E8-23EF116FFE07Q24296427-B1E81EA3-07A9-4EA8-A6AC-C1C8ACA39437Q24298525-5ACBF28A-549A-4EEE-A73E-00D1A26EA7C2Q24298587-884C488A-1DA8-466E-8D6E-EB4BA077C77AQ24299560-FD4638CE-10D1-4479-9813-C857323CD6B1Q24300018-782DEDDE-7415-488E-8C0E-86E3BB3A8CFBQ24302271-5A6B64B5-3F51-4A2D-82C9-AB506742E19FQ24303617-6E0A081D-0A49-488A-9083-463CF1E6F22FQ24309124-83268CD9-E7BC-4360-9FA3-43AF7C0C86E2Q24314412-A27608DD-70EF-478C-B7F1-AD28D943A241Q24314809-E4CBA601-FA1F-46B9-AA23-5374D1D56870Q24314834-F5EC68A4-8A9C-4332-8673-A11658B415CCQ24317768-FB86EA3F-C10F-4AE2-BA7B-6F7CD379DAF5Q24323982-CF332F41-6051-4607-900B-D96AEA68FA8BQ24607952-3792139D-DC2C-47AA-8403-4C44C6DA5D63Q24678892-4927E20A-BEA9-4961-995C-2464B736A7BEQ28115027-FDA707F5-7140-41A4-B21F-F746870156E9Q33112683-FEC14CCF-4C9D-48D3-8812-2698DBD7562CQ33112684-2885DA51-50D9-40AB-BF31-00F9EDFE16D5Q33112696-1E4AE74D-5D87-419A-AC79-EC658A31F5EDQ36638165-F27C7C54-37E5-462B-A984-5C114208149AQ40722503-DCF61D8F-E84D-4582-A187-6524EF00B23BQ42370226-5A17337E-1E01-4834-BC74-6E114C48DDAAQ47037320-E9A4FE7C-E72E-496B-96E6-08D24EB6F589Q50062976-E6296943-4DBA-42B0-B6EE-FFA24358BF95
P921
description
Any process that stops, preven ...... ate or extent of angiogenesis.
@en
biologisch proces
@nl
name
negativ regulering av angiogenese
@nn
negative regulation of angiogenesis
@en
type
label
negativ regulering av angiogenese
@nn
negative regulation of angiogenesis
@en
altLabel
GO:0016525
@en
down regulation of angiogenesis
@en
down-regulation of angiogenesis
@en
downregulation of angiogenesis
@en
prefLabel
negativ regulering av angiogenese
@nn
negative regulation of angiogenesis
@en
P128
P2888
P686
GO:0016525